Immune system, cell senescence, aging and longevity - inflamm-aging reappraised

Current Pharmaceutical Design

Volumn 19, Issue 9, 2013, Pages 1675-1679

  Salvioli, Stefano ^a,b   Monti, Daniela ^c   Lanzarini, Catia ^a,b   Conte, Maria ^a,b   Pirazzini, Chiara ^a,b   Bacalini, Maria Giulia ^a   Garagnani, Paolo ^a,b   Giuliani, Cristina ^a   Fontanesi, Elisa ^a   Ostan, Rita ^a   Bucci, Laura ^a,b   Sevini, Federica ^a   Yani, Stella Lukas ^a,b   Barbieri, Annalaura ^a,b   Lomartire, Laura ^a,b   Borelli, Vincenzo ^a,b   Vianello, Dario ^a   Bellavista, Elena ^a,b   Martucci, Morena ^a   Cevenini, Elisa ^a   Pini, Elisa ^a,b   Scurti, Maria ^a   Biondi, Fiammetta ^a   Santoro, Aurelia ^a   Capri, Miriam ^a,b   Franceschi, Claudio ^a,b   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Interdepartmental Cen for Studies on Biophysics Bioinformatics and Biocomplex 'L Galvani' (CIG)   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Aging; Cell senescence; Centenarians; Immunosenescence; Inflammation

Indexed keywords

AUTACOID; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MITOCHONDRIAL DNA; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

AGING; APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL AGING; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNE SYSTEM; IMMUNOPHENOTYPING; INFLAMMATION; INFLAMMATORY DISEASE; LONGEVITY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SENESCENCE;

EID: 84876721938     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319090015     Document Type: Article

References (65)

1. Fulop T, Franceschi C, Hirokawa K, Pawelec G Eds. Handbook on Immunosenescence-Basic Understanding and Clinical Applications. 2009, Springer.
2. Franceschi C, Bonafè M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 2000; 18: 1717-20.
3. Larbi A, Franceschi C, Mazzatti D, Solana R, Wikby A, Pawelec G. Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda) 2008; 23: 64-74.
4. Horiuchi S, Wilmoth JR. Age patterns of the life table aging rate for major causes of death in Japan 1951-1990. J Gerontol A Biol Sci Med Sci 1997; 52: B67-77.
5. Wikby A, Johansson B, Ferguson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 1994; 29: 531-41.
6. Wikby A, Johansson B, Olsson J, Löfgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 2002; 37: 445-53.
7. Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005; 60: 556-65.
8. Strindhall J, Nilsson BO, Löfgren S, et al. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007; 42: 753-61.
9. Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23: 2375-8.
10. Zanni F, Vescovini R, Biasini C, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 2003; 38: 981-7.
11. Blagosklonny MV, Hall MN. Growth and aging: a common molecular mechanism. Aging (Albany NY) 2009; 1: 357-62.
12. Blagosklonny MV. Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program. Cell Cycle 2010; 9: 3151-6.
13. Salvioli S, Olivieri F, Marchegiani F, et al. Genes, aging and longevity in humans: problems, advantages and perspectives. Free Radic Res 2006; 40: 1303-23.
14. Franceschi C, Capri M, Monti D, et al. Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Aging Dev 2007; 128: 92-105.
15. Gerli R, Monti D, Bistoni O, et al. Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Aging Dev 2000; 121: 37-46.
16. Coppola R, Mari D, Lattuada A, Franceschi C. Von Willebrand factor in Italian centenarians. Haematologica 2003; 88: 39-43.
17. Passeri G, Pini G, Troiano L, et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003; 88: 5109-15.
18. Gangemi S, Basile G, Monti D, et al. Age-related modifications in circulating IL-15 levels in humans. Mediators Inflamm 2005; 2005: 245-7.
19. Baggio G, Donazzan S, Monti D, et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998; 12: 433-7.
20. Paolisso G, Barbieri M, Rizzo MR, et al. Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. Exp Gerontol 2001; 37: 149-56.
21. Akushevich I, Veremeyeva G, Kravchenko J, et al. New stochastic carcinogenesis model with covariates: an approach involving intracellular barrier mechanisms. Math Biosci 2012; 236: 16-30.
22. Pavlidis N, Stanta G, Audisio RA. Cancer prevalence and mortality in centenarians: A systematic review. Crit Rev Oncol Hematol 2012; 83: 145-52.
23. Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest 2007;117: 3988-4002.
24. Studebaker AW, Storci G, Werbeck JL, et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 2008; 68: 9087-95.
25. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008; 88: 1379-406.
26. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
27. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
28. Vazzana N, Santilli F, Sestili S, Cuccurullo C, Davi G. Determinants of increased cardiovascular disease in obesity and metabolic syndrome. Curr Med Chem 2011; 18: 5267-80.
29. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012; 15: 12-22.
30. Washington TA, White JP, Davis JM, et al. Skeletal muscle mass recovery from atrophy in IL-6 knockout mice. Acta Physiol (Oxf) 2011; 202: 657-69.
31. Giuliani N, Sansoni P, Girasole G, et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age-and menopause-related changes. Exp Gerontol 2001; 36: 547-57.
32. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2011; 10: 319-29.
33. Vescovini R, Biasini C, Fagnoni FF, et al. Massive load of functional effector CD4+ and CD8+ T cells against cytomegalovirus in very old subjects. J Immunol 2007; 179: 4283-91.
34. Vescovini R, Biasini C, Telera AR, et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 2010; 184: 3242-9.
35. Derhovanessian E, Maier AB, Hähnel K, et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 2011; 92: 2746-56.
36. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012; Epub ahead of print.
37. Bartlett DB, Firth CM, Phillips AC, et al. The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell 2012; Epub ahead of print.
38. Rathinam VA, Jiang Z, Waggoner SN, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11: 395-402.
39. Jacobs SR, Damania B. NLRs, inflammasomes, and viral infection. J Leukoc Biol 2012; [Epub ahead of print].
40. Ottaviani E, Valensin S, Franceschi C. The neuro-immunological interface in an evolutionary perspective: the dynamic relationship between effector and recognition systems. Front Biosci 1998; 3: d431-5.
41. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908: 244-54.
42. Stout-Delgado HW, Vaughan SE, Shirali AC, Jaramillo RJ, Harrod KS. Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. J Immunol 2012; 188: 2815-24.
43. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011; 243: 206-14.
44. Miao EA, Leaf IA, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010; 11: 1136-42.
45. Jylhävä J, Kotipelto T, Raitala A, Jylhä M, Hervonen A, Hurme M. Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the Vitality 90+ study. Mech Aging Dev 2011; 132: 20-6.
46. Jylhävä J, Jylhä M, Lehtimäki T, Hervonen A, Hurme M. Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study. Exp Gerontol 2012; 47: 372-8.
47. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-7.
48. Chaung WW, Wu R, Ji Y, Dong W, Wang P. Mitochondrial transcription factor A is proinflammatory mediator in hemorrhagic shock. Int J Mol Med 2012; 30: 199-203.
49. Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol 2008; 152: 448-55.
50. Salvioli S, Capri M, Tieri P, et al. Different types of cell death in organismal aging and longevity: state of the art and possible systems biology approach. Curr Pharm Des 2008; 14: 226-36.
51. Salminen A, Ojala J, Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol Life Sci 2011; 68: 1021-31.
52. Monti D, Salvioli S, Capri M, et al. Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech Ageing Dev 2000; 121: 239-50.
53. Feng Z, Hu W, Teresky AK, Hernando E, Cordon-Cardo C, Levine AJ. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci USA 2007; 104: 16633-8.
54. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev 2008; 7: 83-105.
55. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 2010; 16: 238-46.
56. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-45.
57. Paolisso G, Gambardella A, Balbi V, Ammendola S, D'Amore A, Varricchio M. Body composition, body fat distribution, and resting metabolic rate in healthy centenarians. Am J Clin Nutr 1995; 62: 746-50.
58. Paolisso G, Barbieri M, Bonafè M, Franceschi C. Metabolic age modelling: the lesson from centenarians. Eur J Clin Invest 2000; 30: 888-94.
59. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7
60. Bonafè M, Storci G, Franceschi C. Inflamm-aging of the stem cell niche: breast cancer as a paradigmatic example: breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays 2012; 34: 40-9.
61. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
62. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192: 547-56.
63. Storci G, Sansone P, Mari S, et al. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype. J Cell Physiol 2010; 225: 682-91.
64. Terry DF, Wyszynski DF, Nolan VG, et al. Serum heat shock protein 70 level as a biomarker of exceptional longevity. Mech Ageing Dev 2006; 127: 862-8.
65. Terry DF, Wilcox MA, McCormick MA, et al. Lower all-cause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc 2004; 52: 2074-6.